Evidence map›Paper›PMID 38371487›Full record

ReviewVeterinary medicine (Auckland, N.Z.)2024

Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies.

Yvonne Drechsler, Charli Dong, David E Clark, Gagandeep Kaur

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary medicine (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Ameliorative effects ofThe journal of allergy and clinical immunology. Global · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Oral Administration ofAnimals : an open access journal from MDPI · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pharmacokinetics of Ilunocitinib, a New Janus Kinase Inhibitor, in Dogs.Journal of veterinary pharmacology and therapeutics · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yvonne DrechslerCollege of Veterinary Medicine, Western University of Health Sciences, Pomona, CA, USA.ORCID 0000-0001-6923-8509
Charli DongAnimal Dermatology Clinic, Pasadena, CA, USA.
David E ClarkCollege of Veterinary Medicine, Western University of Health Sciences, Pomona, CA, USA.
Gagandeep KaurCollege of Veterinary Medicine, Western University of Health Sciences, Pomona, CA, USA.
Western University of Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common inflammatory and pruritic allergic skin disease in humans and dogs worldwide. The pathogenesis of AD is multifactorial, immunologically complex, and may involve genetic factors, epidermal barrier dysfunction, microbiome changes, immune dysregulation, and allergic sensitization. Across species, prevalence of AD is on the rise. At present, there is no cure for canine AD (CAD). The treatment for CAD is multifaceted and aimed at controlling the pruritus, associated inflammation, and infections, repairing the skin barrier function, and dietary management. This review presents data on prevalence, impact, and complex immunological interactions in AD with a focus on subsequent management of the disease in the canine population. A multimodal approach for management of CAD to address varying clinical signs and responses to therapies is discussed.

Indexed as

alarminsimmune therapiesimmunopathologypruritussystemic therapiestopical therapies

Identifiers

PMID38371487
PMCPMC10874193
OpenAlexW4391787317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.